343 related articles for article (PubMed ID: 29843822)
1. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model.
Contreras A; Beems MV; Tatar AJ; Sen S; Srinand P; Suresh M; Luther TK; Cho CS
J Immunother Cancer; 2018 May; 6(1):41. PubMed ID: 29843822
[TBL] [Abstract][Full Text] [Related]
2. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
3. Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity in mice.
Mahvi DA; Meyers JV; Tatar AJ; Contreras A; Suresh M; Leverson GE; Sen S; Cho CS
J Immunother; 2015; 38(2):54-61. PubMed ID: 25658614
[TBL] [Abstract][Full Text] [Related]
4. Early effector cells survive the contraction phase in malaria infection and generate both central and effector memory T cells.
Opata MM; Carpio VH; Ibitokou SA; Dillon BE; Obiero JM; Stephens R
J Immunol; 2015 Jun; 194(11):5346-54. PubMed ID: 25911759
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
[TBL] [Abstract][Full Text] [Related]
6. Lack of Sprouty 1 and 2 enhances survival of effector CD8
Shehata HM; Khan S; Chen E; Fields PE; Flavell RA; Sanjabi S
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8939-E8947. PubMed ID: 30126987
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
[TBL] [Abstract][Full Text] [Related]
8. Memory T cells are uniquely resistant to melanoma-induced suppression.
Wentworth L; Meyers JV; Alam S; Russ AJ; Suresh M; Cho CS
Cancer Immunol Immunother; 2013 Jan; 62(1):149-59. PubMed ID: 22865267
[TBL] [Abstract][Full Text] [Related]
9. Early Inhibition of Fatty Acid Synthesis Reduces Generation of Memory Precursor Effector T Cells in Chronic Infection.
Ibitokou SA; Dillon BE; Sinha M; Szczesny B; Delgadillo A; Reda Abdelrahman D; Szabo C; Abu-Elheiga L; Porter C; Tuvdendorj D; Stephens R
J Immunol; 2018 Jan; 200(2):643-656. PubMed ID: 29237780
[TBL] [Abstract][Full Text] [Related]
10. Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.
Quinn M; Turula H; Tandon M; Deslouches B; Moghbeli T; Snyder CM
J Immunol; 2015 Feb; 194(4):1726-1736. PubMed ID: 25595792
[TBL] [Abstract][Full Text] [Related]
11. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I
J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929
[TBL] [Abstract][Full Text] [Related]
12. Administration of sulfosuccinimidyl-4-[N-maleimidomethyl] cyclohexane-1-carboxylate conjugated GP100(25-33) peptide-coupled spleen cells effectively mounts antigen-specific immune response against mouse melanoma.
Chang X; Xia CQ
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):46-52. PubMed ID: 26545782
[TBL] [Abstract][Full Text] [Related]
13. Individual Effector/Regulator T Cell Ratios Impact Bone Regeneration.
Schlundt C; Reinke S; Geissler S; Bucher CH; Giannini C; Märdian S; Dahne M; Kleber C; Samans B; Baron U; Duda GN; Volk HD; Schmidt-Bleek K
Front Immunol; 2019; 10():1954. PubMed ID: 31475013
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
15. Adoptive CD8
Fu J; Yu A; Tang J; He B; Chen W
Am J Transl Res; 2020; 12(11):7262-7274. PubMed ID: 33312365
[TBL] [Abstract][Full Text] [Related]
16. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
Rolle CE; Carrio R; Malek TR
Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
[TBL] [Abstract][Full Text] [Related]
18.
Hu X; Majchrzak K; Liu X; Wyatt MM; Spooner CJ; Moisan J; Zou W; Carter LL; Paulos CM
Cancer Res; 2018 Jul; 78(14):3888-3898. PubMed ID: 29769201
[TBL] [Abstract][Full Text] [Related]
19. Differential requirement of perforin and IFN-gamma in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen.
Prévost-Blondel A; Neuenhahn M; Rawiel M; Pircher H
Eur J Immunol; 2000 Sep; 30(9):2507-15. PubMed ID: 11009083
[TBL] [Abstract][Full Text] [Related]
20. The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis.
Gerlach C; Moseman EA; Loughhead SM; Alvarez D; Zwijnenburg AJ; Waanders L; Garg R; de la Torre JC; von Andrian UH
Immunity; 2016 Dec; 45(6):1270-1284. PubMed ID: 27939671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
